ArticlePatient preference and adherence2025
Barriers to the Prevention of Insulin Injection-Associated Lipohypertrophy for Individuals with Diabetes.
Article in Patient preference and adherence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aims and Objectives: This study aimed to explore barriers to preventing lipohypertrophy for individuals with diabetes. Design: A qualitative descriptive design was used. Methods: 17 individuals with diabetes with LH were interviewed face-to-face in individual semi-structured interviews. Qualitative content analysis was used, and data saturation was achieved. Results: The analysis yielded three primary themes with eight subthemes: lack of knowledge (insufficient health education, forgetfulness, and misconceptions), limited feasibility (several limitations in site rotation, financial pressures in needle replacement, and failure to self-monitor flat LH), and low motivation (low perceived severity and low perceived susceptibility). Conclusion: Identifying these barriers provides patients with targeted recommendations or measures to improve LH prevention, further improving self-management at home and diabetes outcomes. Relevance for Clinical Practice: LH is a common insulin therapy complication that affects insulin absorption and glycemic control. The correct injection technique for preventing LH depends on the effectiveness of insulin therapy in individuals with diabetes. Patient or Public Contribution: 17 individuals with type 2 diabetes who participated in the interviews contributed to this study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.